CCO Expert Recap

CCO Expert Recap of data from the 2004 Annual Meeting of the American Association for the Study of Liver Diseases

Source: 2004 Annual Meeting of The American Association for the Study of Liver Diseases*

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.

Hepatitis C Report From the 55th Annual Meeting of the AASLD

Program Director: Patrick J. Lynch, MD

Faculty:

Gary L. Davis, MDAdrian M. Di Bisceglie, MD, FACPKaren L. Lindsay, MD
  • Gary L. Davis, MD
  • Adrian M. Di Bisceglie, MD, FACP
  • Karen L. Lindsay, MD

CME CREDIT INFORMATION

Release Date: 12/02/04

Expiration Date: 12/01/05


Physicians: maximum of 0.5 AMA PRA Category 1 Credits™

Status: Please log in to view status
Begin the CCO Expert Recap

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Describe results from trials of drugs in development for the treatment of HCV infection.

  • Discuss new insights into factors complicating successful treatment, including HIV coinfection, side effects, HCV genotype and race.

  • Review results from recent studies evaluating the use of FDA-approved agents for first-line treatment of HCV infection.

Slideset

CCO Slideset – Hepatitis C: CCO Independent Conference Coverage of the 2004 Annual Meeting of the AASLD*


Format: Microsoft PowerPoint (.ppt) | File size: 400 KB


Jointly sponsored by Northwestern University’s Feinberg School of Medicine and Clinical Care Options, LLC.

Educational grant provided by:

Educational grants support only the CME-certified components of this program.